Literature DB >> 24522779

Interferon responses in HIV infection: from protection to disease.

Aida Sivro1, Ruey-Chyi Su, Francis A Plummer, T Blake Ball.   

Abstract

Interferons, induced early during viral infections, represent important regulators of both innate and adaptive immune responses, and provide protective effects against a wide range of pathogens, including HIV. Several in vitro studies and some in vivo data from HIV-exposed seronegative cohorts indicate that interferons and interferon-mediated immune responses are crucial in preventing early HIV replication. Following establishment of HIV infection, the uncontrolled (aberrant) activation of the immune system, in part regulated by interferon levels, contributes to HIV-1-induced immune activation and disease progression. Modulation of interferon responses prior to and during HIV infection shows promise for development of novel therapeutics to prevent HIV transmission, clear HIV infection, and dampen chronic immune activation. In this review we discuss the role that interferons play in protection from HIV infection, acute infection, and their role in HIV pathogenesis and disease progression. Lastly, we review recent advances in modulating interferon responses for purposes of developing novel HIV therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24522779

Source DB:  PubMed          Journal:  AIDS Rev        ISSN: 1139-6121            Impact factor:   2.500


  18 in total

1.  SIV-Induced Immune Activation and Metabolic Alterations in the Dorsal Root Ganglia During Acute Infection.

Authors:  Lisa M Mangus; Rachel L Weinberg; Audrey C Knight; Suzanne E Queen; Robert J Adams; Joseph L Mankowski
Journal:  J Neuropathol Exp Neurol       Date:  2019-01-01       Impact factor: 3.685

2.  HIV-1 Vif suppresses antiviral immunity by targeting STING.

Authors:  Yu Wang; Gui Qian; Lingyan Zhu; Zhuo Zhao; Yinan Liu; Wendong Han; Xiaokai Zhang; Yihua Zhang; Tingrong Xiong; Hao Zeng; Xianghui Yu; Xiaofang Yu; Xiaoyan Zhang; Jianqing Xu; Quanming Zou; Dapeng Yan
Journal:  Cell Mol Immunol       Date:  2021-11-22       Impact factor: 11.530

3.  IFN-ε protects primary macrophages against HIV infection.

Authors:  Carley Tasker; Selvakumar Subbian; Pan Gao; Jennifer Couret; Carly Levine; Saleena Ghanny; Patricia Soteropoulos; Xilin Zhao; Nathaniel Landau; Wuyuan Lu; Theresa L Chang
Journal:  JCI Insight       Date:  2016-12-08

4.  On the Death Rate of Abortively Infected Cells: Estimation from Simian-Human Immunodeficiency Virus Infection.

Authors:  Ruian Ke; Mian-Er Cong; David Li; J Gerardo García-Lerma; Alan S Perelson
Journal:  J Virol       Date:  2017-08-24       Impact factor: 5.103

5.  Effects of Morphine on Gp120-induced Neuroinflammation Under Immunocompetent Vs. Immunodeficient Conditions.

Authors:  Dalton Canonico; Sadie Casale; Tristan Look; Ling Cao
Journal:  J Neuroimmune Pharmacol       Date:  2022-01-21       Impact factor: 7.285

6.  Naturally Occurring Fc-Dependent Antibody From HIV-Seronegative Individuals Promotes HIV-Induced IFN-α Production.

Authors:  Thomas Lum; Jon A Green
Journal:  Sci Rep       Date:  2016-11-24       Impact factor: 4.379

7.  Anandenanthera colubrina (Vell.) Brenan as an inhibitor of HIV-1 BaL infection.

Authors:  Carolina Medeiros de Almeida Maia; Silvana Pasetto; Joanda Paola Raimundo E Silva; Josean Fechine Tavares; Edja Maria Melo de Brito Costa; Ramiro Mendonça Murata
Journal:  Nat Prod Res       Date:  2021-03-17       Impact factor: 2.488

8.  Effects of HIV gp120 on Neuroinflammation in Immunodeficient vs. Immunocompetent States.

Authors:  Taxiarhia J Arabatzis; Alexa A Wakley; Virginia D McLane; Dalton Canonico; Ling Cao
Journal:  J Neuroimmune Pharmacol       Date:  2020-07-06       Impact factor: 7.285

9.  Further Evidence that Human Endogenous Retrovirus K102 is a Replication Competent Foamy Virus that may Antagonize HIV-1 Replication.

Authors:  Marian P Laderoute; Louise J Larocque; Antonio Giulivi; Francisco Diaz-Mitoma
Journal:  Open AIDS J       Date:  2015-12-07

10.  Reducing IRF-1 to Levels Observed in HESN Subjects Limits HIV Replication, But Not the Extent of Host Immune Activation.

Authors:  Ruey-Chyi Su; Andrew Plesniarski; Zhujun Ao; Joshua Kimani; Aida Sivro; Walter Jaoko; Frank A Plummer; Xiaojian Yao; Terry Blake Ball
Journal:  Mol Ther Nucleic Acids       Date:  2015-10-27       Impact factor: 10.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.